Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

October 01, 1996; 47 (4) ARTICLES

Single large-scale mitochondrial DNA deletion in a patient with mitochondrial myopathy associated with multiple symmetric lipomatosis

Y. Campos, M. A. Martin, C. Navarro, P. Gordo, J. Arenas
First published October 1, 1996, DOI: https://doi.org/10.1212/WNL.47.4.1012
Y. Campos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. A. Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Navarro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Gordo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Arenas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Single large-scale mitochondrial DNA deletion in a patient with mitochondrial myopathy associated with multiple symmetric lipomatosis
Y. Campos, M. A. Martin, C. Navarro, P. Gordo, J. Arenas
Neurology Oct 1996, 47 (4) 1012-1014; DOI: 10.1212/WNL.47.4.1012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
26

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

In a nonalcoholic woman with multiple symmetric lipomatosis (MSL), muscle histochemistry showed ragged-red fibers and cytochrome c oxidase negative fibers. Southern blot analysis revealed a single deletion of mitochondrial DNA (mtDNA). We suggest that MSL is an uncommon manifestation of the wide clinical spectrum of mitochondrial disorders, in particular of those associated with single mtDNA deletions.

NEUROLOGY 1996;47: 1012-1014

Multiple symmetric lipomatosis (MSL) (Launois-Bensaude syndrome, Madelung's disease) is a rare disorder of middle life characterized by large nonencapsulated lipomas distributed around the neck, shoulders, and other axial regions. [1] Neurologic involvement, particularly peripheral neuropathy, is considered an integral part of the MSL syndrome. [1] Alcoholism is frequently associated with MSL. [1] Recently, Berkovic et al. [2] reported an association between MSL and mitochondrial dysfunction. Moreover, further recent reports documented that some patients with MSL harbor mutations in the mitochondrial genome, in particular multiple mtDNA deletions, [3,4] or the mutation at nucleotide position (np) 8344 in the tRNALys gene of mtDNA. [5-8] Here, we present the first report of a patient with MSL harboring a single large-scale mtDNA deletion.

Case report.

A 60-year-old nonalcoholic woman had a 28-year history of slowly progressive proximal muscle weakness and bilateral ptosis. She had neurosensory hearing loss and tension headache, but no other neurologic symptoms. At age 41 years, large confluent symmetric lipoma developed around the neck in a "horse-collar" distribution. Examination at age 59 years revealed bilateral ptosis without diplopia, and symmetric proximal weakness without wasting, affecting muscles in her upper limbs and especially in her lower limbs. She had exercise intolerance and complained of muscle pain on repeated muscle testing. Deep tendon reflexes were normal.

Cranial nerve examination was normal aside from hearing loss. Extraocular muscles were apparently uninvolved. Ophthalmoscopic examination was normal. Tibial and sural nerve conduction studies were normal, and needle electromyography showed a myopathic pattern. Electrocar-diographic studies showed right bundle branch block. Blood chemistry, including uric acid, and hematologic studies were normal.

A recent clinical reevaluation revealed mild extraocular muscle weakness.

Methods.

Muscle biopsy and histochemistry.

A muscle biopsy specimen was taken from the rectus femoris, frozen, and stored in liquid nitrogen until analysis. Serial frozen sections of muscle were tested with a battery of histologic stains and cytochemical reactions, including combined staining for cytochrome c oxidase (COX) and succinate dehydrogenase (SDH). [9]

Muscle biochemistry.

The activities of NADH dehydrogenase, rotenone-sensitive NADH cytochrome c reductase, SDH, succinate cytochrome c reductase, COX, and citrate synthase were measured in muscle homogenates as described. [10] The activity of each complex was normalized to that of citrate synthase for correcting to mitochondrial volume.

Molecular genetic studies.

Total DNA was isolated from frozen muscle samples by phenol extraction. For Southern blot analysis, DNA was digested with Pvu II or BamHI, separated by agarose gel electrophoresis (0.8%), and transferred onto nitrocellulose membranes as reported. [11] The filters were hybridized with entire human mtDNA labelled with digoxigenin-alkaline phosphatase (Boehringer Mannheim). The deletion was mapped by PCR and restriction analysis as described. [11] To detect "the MERRF point mutation" (at np 8344 within the tRNALys gene), we used a method described elsewhere. [5]

Results.

Sections stained with modified Gomori trichrome revealed ragged-red fibers (RRF). These fibers showed strong SDH activity, representing about 10% of fibers. COX activity was absent or deficient in about 20% of fibers. All RRF stained negative for COX, but some COX-negative fibers were not RRF.

Muscle biochemistry was normal; in particular, COX activity was within normal range. Southern blot analysis showed the presence of two populations of mtDNA, one corresponding to full-length genome (16.5 Kb) and the other corresponding to a shorter molecule of approximately 13.9 Kb Figure 1. The proportion of deleted mtDNA was 47%. The deletion spanned from np 10256-10300, at the ND3 gene, to np 12550-12680, at the ND5 gene, encompassing ND3, ND4L, ND4, and ND5 subunits, and several tRNA genes (see Figure 1).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. (a) Southern blot analysis. DNA was digested with BamHI, electrophoresed through a 0.8% agarose gel, transferred to nitrocellulose, and probed with labeled mtDNA. Sizes, in Kb, are shown on left (calculated on the basis of lambda digested with HindIII as markers). In muscle, we found two hybridizing bands: a normal-sized mtDNA of 16.5 Kb and a more rapidly migrating band (13.9 Kb) due to a deletion of 2.6 Kb. (b) Linearized physical map of the human mitochondrial genome and the deleted regions of mutant mtDNA in the patient. The dotted region is the extent of deletion and the hatched regions define upper and lower limits. 12S and 16S = ribosomal RNA genes; ND = NADH dehydrogenase (complex I) subunits; CO = cytochrome c oxidase (complex IV) subunits; ATPase 8/6 = complex V subunits; cyt b = apocytochrome b.

Discussion.

We studied a nonalcoholic woman with MSL, ptosis, proximal weakness, neurosensory hearing loss, mitochondrial dysfunction in skeletal muscle, and no peripheral neuropathy. Molecular genetic analysis revealed a single mtDNA deletion. MSL is sometimes associated with mtDNA mutations, in particular with multiple deletions [3,4] and with the point mutation at np 8344 in the tRNALys gene [5-8] Table 1. However, there is no report on patients with MSL harboring a single mtDNA deletion. Berkovic et al. [2] described four MSL patients with mitochondrial abnormalities. Of them, one had proximal weakness, bilateral ptosis, and hearing loss, taking part of a more complex syndrome involving peripheral nerve and CNS. Klopstock et al. [3] documented muscle mitochondrial dysfunction in 7 of 11 patients with MSL. Of them, one harbored multiple deletions of mtDNA in muscle and showed peripheral neuropathy, ataxia, and dysarthria as the most prominent clinical features. Moreover, some patients with MERRF syndrome harboring the 8344 np mutation presented with cervical lipomas resembling those of MSL. [5,6,8]

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1. Clinical, morphologic, and molecular genetic data of eight patients with MSL and mitochondrial dysfunction

Respiratory chain was normal, but there was focal COX deficiency, particularly in RRF, indicating that 20% of fibers had impairment of mitochondrial protein synthesis. Although the patient had 47% of mutant genomes in muscle, the presence of COX-deficient fibers suggests the accumulation in RRF of deleted mtDNA to levels over 60%.

MSL is a heterogeneous disorder frequently associated with alcoholism. [1] A recent report documented normal respiratory chain in muscle from chronic alcoholic patients, thus alcoholism seems unrelated to mitochondrial metabolism in alcoholic MSL patients. [12] Among nonalcoholic patients, there is a subgroup of patients without mitochondrial abnormalities, [3,13] while another shows mitochondrial dysfunction in muscle. [2,3] Even among patients with mitochondrial involvement, the clinical spectrum has a wide range, varying from severe encephalomyopathy, e.g., MERRF, to ocular myopathy. On the other hand, clinical variability occurs in patients with mtDNA deletions. We suggest that MSL is an additional, uncommon manifestation of the wide clinical spectrum of mitochondrial disorders, in particular of those associated with mtDNA deletions.

The reasons for this broad variability may relate to the different distribution of deleted and wild-type mtDNA in different tissues. Our patient conceivably had higher percentages of mutant genomes in clinically affected organs like lipomatous tissue or muscle. In fact, Holme et al. [7] found a high proportion of mutant mtDNA in lipomas from a MERRF patient. However, the relation between MSL and mitochondrial dysfunction is unclear. Although the microscopic appearance of lipomas in MSL is similar to that of white fat, brown fat is normally located in the cervical region where lipomas develop in MSL. [14] Moreover, brown adipose tissue has abundant mitochondria and a great fat turnover coupled with a particularly high activity of the mitochondrial respiratory chain. [14] A mitochondrial dysfunction could therefore lead to progressive lipid storage, making brown fat similar to white fat, thus explaining why the microscopic appearance of MSL adipose tissue resembles that of white fat.

Acknowledgment

We are indebted to Dr. Juan Trueba, consultant neurologist of the Hospital 12 de Octubre.

  • Copyright 1996 by Advanstar Communications Inc.

REFERENCES

  1. 1.↵
    Enzi G. Multiple symmetrical lipomatosis: an updated clinical report. Medicine 1984;63:56-64.
    OpenUrl
  2. 2.↵
    Berkovic SF, Andermann F, Shoubridge EA, et al. Mitochondrial dysfunction in multiple symmetrical lipomatosis. Ann Neurol 1991;29:566-569.
    OpenUrlPubMed
  3. 3.↵
    Klopstock T, Naumann M, Schalke B, et al. Multiple symmetric lipomatosis: abnormalities in complex IV and multiple deletions in mitochondrial DNA. Neurology 1994;44:862-866.
    OpenUrl
  4. 4.
    Ciafaloni E, Shanske S, Apostolski S, et al. Multiple deletions of mitochondrial DNA [abstract]. Neurology 1991;41(suppl 1):207.
  5. 5.↵
    Silvestri G, Ciafaloni E, Santorelli FM, et al. Clinical features associated with the A right arrow G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993;43:1200-1206.
    OpenUrlAbstract/FREE Full Text
  6. 6.
    Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlstron J, Aasly J. Segregation and manifestations of the mtDNA tRNA sup Lys A right arrow G sup (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992;51:1201-1212.
    OpenUrlPubMed
  7. 7.↵
    Holme E, Larsson NG, Oldfors A, Tulinius MH, Sahlin P, Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA sup Lys A right arrow G sup (8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1993;52:551-556.
    OpenUrl
  8. 8.
    Calabresi PA, Silvestri G, DiMauro S, Griggs RC. Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF. Muscle Nerve 1994;17:943-945.
    OpenUrlPubMed
  9. 9.↵
    Bonilla E, Sciacco M, Tariji K, et al. New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Path 1992;2:113-119.
    OpenUrlPubMed
  10. 10.↵
    DiMauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987;22:498-506.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Campos Y, Garcia-Silva T, Barrionuevo CR, Cabello A, Muley R, Arenas J. Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes (MELAS) and Fanconi's syndrome. Pediatr Neurol 1995;13:69-72.
    OpenUrl
  12. 12.↵
    Cardellach F, Galofre J, Grau JM, et al. Oxidative metabolism in muscle mitochondria from patients with chronic alcoholism. Ann Neurol 1992;31:515-518.
    OpenUrl
  13. 13.
    Matthews PM, Squier MV, Chalk C, Donaghy M. Mitochondrial abnormalities are not invariably present in neurologic syndromes associated with multiple symmetric lipomatosis. Neurology 1995;45:197-200.
    OpenUrlFREE Full Text
  14. 14.↵
    Zancanaro C, Sbarbati A, Morroni M, et al. Multiple symmetric lipomatosis: ultrastructural investigation of the tissue and preadipocytes in primary culture. Lab Invest 1990;63:253-258.
    OpenUrl

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Case report.
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Autosomal dominant progressive external ophthalmoplegia
    Distribution of multiple mitochondrial DNA deletions
    Ali-Reza Moslemi, Atle Melberg, Elisabeth Holme et al.
    Neurology, July 01, 1999
  • Articles
    Mitochondrial abnormalities in inclusion-body myositis
    A. Oldfors, A. R. Moslemi, L. Jonasson et al.
    Neurology, December 16, 2005
  • Articles
    Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome
    A. Papadimitriou, G. P. Comi, G. M. Hadjigeorgiou et al.
    Neurology, October 01, 1998
  • Articles
    The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO
    C. Fratter, G.S. Gorman, J.D. Stewart et al.
    Neurology, May 17, 2010
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise